These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9685870)

  • 21. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
    Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A
    J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
    Vandervoort J; Ludwig A
    Int J Pharm; 2002 May; 238(1-2):77-92. PubMed ID: 11996812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles.
    Delie F; Berton M; Allémann E; Gurny R
    Int J Pharm; 2001 Feb; 214(1-2):25-30. PubMed ID: 11282232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.
    Ozturk K; Caban S; Kozlu S; Kadayifci E; Yerlikaya F; Capan Y
    Pharmazie; 2010 Sep; 65(9):665-9. PubMed ID: 21038843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencapsulation method.
    Elkharraz K; Ahmed AR; Dashevsky A; Bodmeier R
    Int J Pharm; 2011 May; 409(1-2):89-95. PubMed ID: 21356287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents.
    Manchanda R; Fernandez-Fernandez A; Nagesetti A; McGoron AJ
    Colloids Surf B Biointerfaces; 2010 Jan; 75(1):260-7. PubMed ID: 19775872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compatible ternary blends of chitosan/poly(vinyl alcohol)/poly(lactic acid) produced by oil-in-water emulsion processing.
    Grande R; Carvalho AJ
    Biomacromolecules; 2011 Apr; 12(4):907-14. PubMed ID: 21361270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery.
    Wang N; Wu XS; Li JK
    Pharm Res; 1999 Sep; 16(9):1430-5. PubMed ID: 10496661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
    Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
    Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(D,L-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system.
    Mandal TK; Bostanian LA; Graves RA; Chapman SR
    Pharm Res; 2002 Nov; 19(11):1713-9. PubMed ID: 12458678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
    Oh DH; Balakrishnan P; Oh YK; Kim DD; Yong CS; Choi HG
    Int J Pharm; 2011 Feb; 404(1-2):191-7. PubMed ID: 21055456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabrication of Fucoxanthin-Loaded Microsphere(F-LM) By Two Steps Double-Emulsion Solvent Evaporation Method and Characterization of Fucoxanthin before and after Microencapsulation.
    Noviendri D; Jaswir I; Taher M; Mohamed F; Salleh HM; Noorbatcha IA; Octavianti F; Lestari W; Hendri R; Ahmad H; Miyashita K; Abdullah A
    J Oleo Sci; 2016 Aug; 65(8):641-53. PubMed ID: 27430384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation and toxicity of triptolide-loaded poly (D,L-lactic acid) nanoparticles].
    Liu MX; Dong J; Yang YJ; Yang XL; Xu HB
    Yao Xue Xue Bao; 2004 Jul; 39(7):556-60. PubMed ID: 15493850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase.
    Sheng Y; He H; Zou H
    Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.